These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 19538523)

  • 21. Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men.
    Behre HM; Heinemann L; Morales A; Pexman-Fieth C
    Aging Male; 2008 Jun; 11(2):101-6. PubMed ID: 18570063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dark side of testosterone deficiency: III. Cardiovascular disease.
    Traish AM; Saad F; Feeley RJ; Guay A
    J Androl; 2009; 30(5):477-94. PubMed ID: 19342698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testosterone and erectile physiology.
    Guay AT
    Aging Male; 2006 Dec; 9(4):201-6. PubMed ID: 17178555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic syndrome, testosterone deficiency and erectile dysfunction never come alone.
    Yassin AA; Saad F; Gooren LJ
    Andrologia; 2008 Aug; 40(4):259-64. PubMed ID: 18727737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic.
    Corona G; Mannucci E; Petrone L; Ricca V; Balercia G; Mansani R; Chiarini V; Giommi R; Forti G; Maggi M
    Int J Impot Res; 2006; 18(2):190-7. PubMed ID: 16136189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
    Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
    Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testosterone and erectile dysfunction.
    Yassin AA; Saad F
    J Androl; 2008; 29(6):593-604. PubMed ID: 18641415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen pattern in patients with type 2 diabetes-associated erectile dysfunction: impact of metabolic control.
    El-Sakka AI; Sayed HM; Tayeb KA
    Urology; 2009 Sep; 74(3):552-9. PubMed ID: 19592073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 2 diabetes-associated androgen alteration in patients with erectile dysfunction.
    El-Sakka AI; Sayed HM; Tayeb KA
    Int J Androl; 2008 Dec; 31(6):602-8. PubMed ID: 17877718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Androgen deficit and diabetes].
    Cáp J
    Vnitr Lek; 2012 Mar; 58(3):228-31. PubMed ID: 22486290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal supplementation and erectile dysfunction.
    Aversa A; Isidori AM; Greco EA; Giannetta E; Gianfrilli D; Spera E; Fabbri A
    Eur Urol; 2004 May; 45(5):535-8. PubMed ID: 15082192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controversial aspects of testosterone in the regulation of sexual function in late-onset hypogonadism.
    Maggi M; Filippi S; Vignozzi L; Rastrelli G
    Andrology; 2020 Nov; 8(6):1580-1589. PubMed ID: 32248652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypogonadotrophic hypogonadism in type 2 diabetes.
    Dandona P; Dhindsa S; Chaudhuri A; Bhatia V; Topiwala S
    Aging Male; 2008 Sep; 11(3):107-17. PubMed ID: 18821286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is type 2 diabetes mellitus a cause of severe erectile dysfunction in patients with metabolic syndrome?
    Aslan Y; Sezgin T; Tuncel A; Tekdogan UY; Guler S; Atan A
    Urology; 2009 Sep; 74(3):561-4. PubMed ID: 19604566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
    Miner MM; Seftel AD
    Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone, cardiovascular disease and the metabolic syndrome.
    Corona G; Rastrelli G; Vignozzi L; Mannucci E; Maggi M
    Best Pract Res Clin Endocrinol Metab; 2011 Apr; 25(2):337-53. PubMed ID: 21397202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sexual dysfunction at the onset of type 2 diabetes: the interplay of depression, hormonal and cardiovascular factors.
    Corona G; Giorda CB; Cucinotta D; Guida P; Nada E;
    J Sex Med; 2014 Aug; 11(8):2065-73. PubMed ID: 25041930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hypoactive sexual desire and testosterone deficiency in men].
    Lejeune H; Huyghe É; Droupy S
    Prog Urol; 2013 Jul; 23(9):621-8. PubMed ID: 23830256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptom report and treatment experience of hypogonadal men with and without type 2 diabetes in a United States health plan.
    Shortridge EF; Polzer P; Donga P; Wade RL
    Int J Clin Pract; 2015 Jul; 69(7):783-90. PubMed ID: 25854747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testosterone gel monotherapy improves sexual function of hypogonadal men mainly through restoring erection: evaluation by IIEF score.
    Chiang HS; Cho SL; Lin YC; Hwang TI
    Urology; 2009 Apr; 73(4):762-6. PubMed ID: 19118875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.